Glanbia plc
GL9
Pozycja w akcjach
#3183
Operating globally as a prominent nutrition company, Glanbia plc specializes in... Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Cena akcji
$22.98
Kapitalizacja rynkowa
$5.55B
Zmiana (1 dzień)
-0.20%
Zmiana (1 rok)
32.97%
Kraj
IE
Handel Glanbia plc (GL9)
Kategoria
Consumer Defensive
Zyski dla Glanbia plc (GL9)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Glanbia plc, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Glanbia plc od 2001 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2025 | $217.73M | 1.09% |
| 2024 | $215.38M | -44.90% |
| 2023 | $390.89M | 61.74% |
| 2022 | $241.67M | 34.51% |
| 2021 | $179.67M | 12.53% |
| 2020 | $159.66M | -28.53% |
| 2019 | $223.39M | -27.14% |
| 2018 | $306.59M | 11.24% |
| 2017 | $275.62M | 16.58% |
| 2016 | $236.43M | -0.44% |
| 2015 | $237.46M | 13.07% |
| 2014 | $210.02M | -13.23% |
| 2013 | $242.04M | 22.16% |
| 2012 | $198.12M | 44.96% |
| 2011 | $136.67M | -24.12% |
| 2010 | $180.12M | -12.18% |
| 2009 | $205.09M | 41.00% |
| 2008 | $145.45M | 24.74% |
| 2007 | $116.60M | 35.58% |
| 2006 | $86.00M | 12.04% |
| 2005 | $76.76M | -46.99% |
| 2004 | $144.81M | -872.54% |
| 2003 | $-18.74M | 120.20% |
| 2002 | $-8.51M | -117.62% |
| 2001 | $48.30M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $12.96B | - |
CH
|
|
| - | - |
FR
|
|
| - | - |
JP
|
|
| - | - |
BR
|
|
| $-3.66B | - |
US
|
